Vir Biotechnology, Inc. (VIR) earnings

VIR earnings moved a median of -1.84% by the close. Quarterly and annual VIR reports and results, each read against the price at its own news timestamp. Back to the VIR overview →

30 measured VIR earnings events.

Where these VIR earnings landedvs 30 measured VIR earnings reactions
VIR earningsMiddle 50% · -4.93% to +0.08%Zero: 0.00%Median: -1.84%Median -1.84%-8.00%0+8.00%
Middle 50% of VIR earnings reactions-4.93% to +0.08%
Median reaction (to close)-1.84%
Measured reactions30
Point-in-time · zero look-ahead

Half of the 30 VIR earnings events with a measured close landed between -4.93% and +0.08%; 27% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Vir Biotechnology, Inc. For: Jun 30SEC filing · Form 10-Q-3.02%-8.60%
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial ResultsPress release-3.02%-8.60%
Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial ResultsPress release+1.25%+1.41%
Form 10-Q Vir Biotechnology, Inc. For: Mar 31SEC filing · Form 10-Q-0.81%-5.89%
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial ResultsPress release-0.81%-5.89%
Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial ResultsPress release-1.42%-2.08%
Form 10-K Vir Biotechnology, Inc. For: Dec 31SEC filing · Form 10-K-4.29%-4.14%
Form 10-Q Vir Biotechnology, Inc. For: Sep 30SEC filing · Form 10-Q+3.12%-0.20%
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2025 Financial ResultsPress release+3.12%-0.20%
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025Press release+0.00%-5.09%
Form 10-Q Vir Biotechnology, Inc. For: Jun 30SEC filing · Form 10-Q+3.32%-9.75%
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2025 Financial ResultsPress release+3.32%-9.75%
Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2025 Financial Results on August 6, 2025Press release-2.23%+0.17%
Form 10-Q Vir Biotechnology, Inc. For: Mar 31SEC filing · Form 10-Q-3.10%+1.31%
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial ResultsPress release-3.10%+1.31%
Vir Biotechnology to Provide Corporate Update and Report First Quarter 2025 Financial Results on May 7, 2025Press release-2.94%-0.65%
Form 10-K Vir Biotechnology, Inc. For: Dec 31SEC filing · Form 10-K-0.79%-15.08%
Form 10-Q Vir Biotechnology, Inc. For: Sep 30SEC filing · Form 10-Q-0.54%+3.32%
Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatePress release+8.82%+29.69%
Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024Press release-0.77%-1.55%
Form 10-Q Vir Biotechnology, Inc. For: Jun 30SEC filing · Form 10-Q-2.35%-1.81%
Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline OpportunitiesPress release-2.35%-1.81%
Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024Press release+1.27%-1.86%
Form 10-Q Vir Biotechnology, Inc. For: Mar 31SEC filing · Form 10-Q-0.77%-2.29%
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial ResultsPress release+0.99%+2.57%
Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024Press release-0.22%-2.50%
Form 10-K Vir Biotechnology, Inc. For: Dec 31SEC filing · Form 10-K-3.64%-4.43%
Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024Press release-1.90%-3.34%
Form 10-Q Vir Biotechnology, Inc. For: Sep 30SEC filing · Form 10-Q+0.80%-1.60%
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsPress release+9.00%+5.16%
That’s how VIR usually reacts to earnings — get an email when it moves on news →
Keep exploring

More VIR: analyst actions → · SEC filings → · VIR overview →